Dermapharm Holding SE buy Maxi_Scalibusa
Start price
23.04.19
/
50%
€31.50
Target price
04.11.21
€60.00
Performance (%)
184.60%
End price
05.11.21
€89.65
Summary
This prediction ended on 05.11.21 with a price of €89.65. With a performance of 184.60% the BUY prediction by Maxi_Scalibusa was a big success. Dividends of €1.57 are taken into consideration when calculating the performance. Maxi_Scalibusa has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | 5.306% | 5.306% | -0.258% | 1.097% |
| iShares Core DAX® | 1,43 % | 2,63 % | 12,46 % | 60,35 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % | 1,25 % | 85,81 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % | 27,38 % | 64,40 % |
| iShares S&P 500 | 1,92 % | 1,16 % | 1,63 % | 59,42 % |
Comments by Maxi_Scalibusa for this prediction
In the thread Dermapharm Holding SE diskutieren
In the thread Trading Dermapharm Holding SE
Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten